Naftali Kaminski MD
Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine (Pulmonary); Section Chief (7/1/13 - present)
Departments & Organizations
Genomics; microRNAs; Non-coding RNAs; Biomarkers; Idiopathic Pulmonary Fibrosis and other Interstitial Lung Disease; Advanced Lung Disease; Personalized Medicine; Systems Biology; High-throughput technologies; Matrix Mtealloproteases more...
- B.M., Hebrew University, 1985
- M.D., Hebrew University, 1989